Budesonide orodispersible tablets are superior to maintain combined clinical and histological remission in adult patients with eosinophilic esophagitis: Results from the 48-weeks, double-blind, placebo-controlled pivotal EOS-2 trial
Alex Straumann 1
Alfredo J. Lucendo 2
Stephan Miehlke 3
Michael Vieth 4
Christoph Schlag 5
Luc Biedermann 6
Cecilio Santander Vaquero
Constanza Ciriza De Los Ríos
Dirk Hartmann
Ahmed Madisch
Petr Hruz
Jamal Hayat
Ulrike von Arnim
Arjan Bredenoord
Stefan Schubert
Ralph Müller
Roland Greinwald
Alain Schoepfer
Stephen
1 Swiss EoE Research Network,Olten,Switzerland
2 Hospital General de Tomelloso Dept. of Digestive Health,Tomelloso,Spain
3 Coopertion of Internal Medicine Center for Digestive Diseases,Hamburg,Germany
4 Klinikum Bayreuth Abt. Pathology,Bayreuth,Germany
5 Technische Universität München,München,Germany
6 USZ Z&uu
Conference
UEG Week 2019
Citation
United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]